BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Feb. 27, 2003
View Archived Issues
FDA Approves Guilford's Gliadel As First-Line Therapy For Glioma
The FDA issued Guilford Pharmaceuticals Inc. approval to expand the use of the Gliadel Wafer as a first-line therapy for patients with high-grade malignant glioma. (BioWorld Today)
Read More
Buyouts Making As Much Sense As Collaborations In Some Cases
Read More
Helicobacter pylori Bacteria Holed Up In The Stomach Is Often A Life Sentence Of Gut Damage, Cancer
Read More
Affinium Purchases Preclinical Antibiotic Compounds From GSK
Read More
Hollis-Eden Garners $10 Million With Sale Of Convertible Notes
Read More
Celltech Joins Bidding War For OGS; Offer Called Inadequate'
Read More
Amgen Business Overview Through 2005 Well Received
Read More
Other News To Note
Read More